Counseling the Patient with Potentially HPV-Related Newly Diagnosed Head and Neck Cancer

Finnigan, John P.; Sikora, Andrew G.

doi:10.1007/s11912-013-0375-8

Cited by 11 publications

(10 citation statements)

References 102 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Women have felt stigma, anxiety, concern about their relationships and worry about disclosure of their test results to others, following a diagnosis of HPV in the context of cervical screening [24] . As the link between HPV and HNC has been established, there has been increasing recognition of the need for guidance on how to discuss HPV with patients [25] , [26] , [27] . Behavioural and psychological science has made a significant contribution to understanding and addressing psychosocial issues associated with both HNC and HPV.…”

Section: Introductionmentioning

confidence: 99%

Human Papillomavirus and Head and Neck Cancer: Psychosocial Impact in Patients and Knowledge of the Link – A Systematic Review

2016

View full text Add to dashboard Cite

Head and neck cancer (HNC) currently affects approximately 11 200 people in the UK, with an increasing proportion known to be caused by the human papillomavirus (HPV). We undertook a systematic review of studies measuring the psychosocial impact of HPV-related HNC and also studies measuring knowledge about the link between HPV and HNC among different populations. Searches were conducted on MEDLINE, Embase, PsycINFO, CINAHL Plus and Web of Science, with reference and forward citation searches also carried out on included studies. Studies were selected if they (i) were original peer-reviewed research (qualitative or quantitative), (ii) mentioned HPV and HNC, (iii) measured an aspect of the psychosocial impact of the diagnosis of HPV-related HNC as the dependent variable and/or (iv) measured knowledge of the association between HPV and HNC. In total, 51 papers met the inclusion criteria; 10 measuring psychosocial aspects and 41 measuring knowledge of the link between HPV and HNC. Quality of life in those with HPV-positive HNC was found to be higher, lower or equivalent to those with HPV-negative HNC. Longitudinal studies found quality of life in patients was at its lowest 2–3 months after diagnosis and some studies found quality of life almost returned to baseline levels after 12 months. Knowledge of the link between HPV and HNC was measured among different populations, with the lowest knowledge in the general population and highest in medical and dental professionals. Due to the limited studies carried out with patients measuring the psychosocial impact of a diagnosis of HPV-positive HNC, future work is needed with the partners of HPV-positive HNC patients and health professionals caring for these patients. The limited knowledge of the association between HPV and HNC among the general population also indicates the need for research to explore the information that these populations are receiving.

show abstract

Section: Introductionmentioning

confidence: 99%

Human Papillomavirus and Head and Neck Cancer: Psychosocial Impact in Patients and Knowledge of the Link – A Systematic Review

2016

View full text Add to dashboard Cite

show abstract

“…In addition, the prognostic value of prevalent or persistent HPV detection in oral rinses in predicting risk for OSCC is entirely unknown. It has been suggested that partners of HPV-OSCC patients may be reassured by routine oral cavity and oropharynx screening [123], but there is no evidence to support this recommendation. Indeed, the US Preventive Services Task Force issued a statement in 2013 describing inadequate evidence to recommend screening for oral cancer [124].…”

Section: Introductionmentioning

confidence: 99%

The role of sexual behavior in head and neck cancer: implications for prevention and therapy

Rettig

Kiess

Fakhry

2014

Expert Review of Anticancer Therapy

View full text Add to dashboard Cite

HPV-positive oropharyngeal squamous cell carcinoma (HPV-OSCC) is associated with oral sexual behaviors. The sharp rise in incidence of HPV-OSCC in the USA has been attributed to changes in sexual norms over the past five decades, with lower age at sexual debut and higher numbers of sexual partners per individual. In addition, variations in HPV-OSCC prevalence by race, age cohort and gender may be attributable to differences in oral sexual behaviors among these groups. Oral HPV infection is the putative precursor to HPV-OSCC. Risk factors for oral HPV incidence, prevalence, clearance and persistence are crucial to understanding how, and in whom, oral HPV infection progresses to malignancy. Future investigation should focus on elucidating the natural history of oral HPV infection persistence and malignant transformation, developing effective screening tools and exploring opportunities for prevention such as vaccination and public health education.

show abstract

“… 9 Health professionals must be prepared to discuss HPV status because affected patients may want to know the cause of their condition and may question the implications for their sexual partners. 10 11 Although discussions about HPV between patients and health professionals are becoming more common in cervical disease, patients express concern about the stigma attached to sexual transmission. 12–14 There is little rigorous research into how clinicians communicate with patients for the other cancers associated with HPV.…”

Section: Introductionmentioning

confidence: 99%

Talking about human papillomavirus and cancer: protocol for a patient-centred study to develop scripted consultations

et al. 2016

View full text Add to dashboard Cite

IntroductionPersistent infection with sexually transmitted, high-risk human papillomavirus (HPV) types is the cause of all cervical cancers and some anogenital and oropharyngeal cancers. HPV is an extremely common asymptomatic infection but little known and poorly understood by the public. Patients with HPV-related cancers have new and challenging information needs due to the complex natural history of HPV and the stigma of sexual transmission. They may ask questions that are outside the remit of the traditional cancer consultation, and there is a lack of guidance on how to counsel them. This study aims to fulfil that need by developing and testing cancer site-specific scripted consultations.Methods and analysisA synthesis of findings generated from previous work, a systematic review of information-based interventions for patients with HPV-related cancers, and interviews with cancer clinicians will provide the evidence base underpinning provisional messages. These will be explored in three phases of face-to-face interviews with 75–90 purposively selected patients recruited in cancer clinics to: (1) select and prioritise the most salient messages, (2) phrase the messages appropriately in plain English and, (3) test their acceptability and usefulness. Phases 1 and 2 will draw on card-sorting methods used in website design. In phase three, we will create cancer site-specific versions of the script and test them using cognitive interviewing techniques.Ethics and disseminationThe study has received ethical approval. Findings will be published in a peer-reviewed journal. The final product will be cancer-specific scripted consultations, most likely in the form of a two-sided information sheet with the most important messages to be conveyed in a consultation on one side, and frequently asked questions for later reading on the reverse. However, they will also be appropriate and readily adaptable to web-based uses.

show abstract

Counseling the Patient with Potentially HPV-Related Newly Diagnosed Head and Neck Cancer

Cited by 11 publications

References 102 publications

Human Papillomavirus and Head and Neck Cancer: Psychosocial Impact in Patients and Knowledge of the Link – A Systematic Review

Human Papillomavirus and Head and Neck Cancer: Psychosocial Impact in Patients and Knowledge of the Link – A Systematic Review

The role of sexual behavior in head and neck cancer: implications for prevention and therapy

Talking about human papillomavirus and cancer: protocol for a patient-centred study to develop scripted consultations

Contact Info

Product

Resources

About